phenylalanine has been researched along with Weight Loss in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Clement, D; Houchard, A; Keeber, L; Kulke, M; Pavel, M; Srirajaskanthan, R; Weickert, MO | 1 |
| Berger, K; Fuchs, D; Strasser, B | 1 |
| Baker, SK; Breen, L; Churchward-Venne, TA; Hector, AJ; Marcotte, GR; Murphy, CH; Phillips, SM; von Allmen, M | 1 |
| Benninger, C; Blackburn, GL; Butchko, HH; Comer, CP; de Sonneville, LM; Geha, RS; Hertelendy, Z; Koestner, A; Leon, AS; Liepa, GU; Mayhew, DA; McMartin, KE; Mendenhall, CL; Munro, IC; Novotny, EJ; Renwick, AG; Schiffman, SS; Schomer, DL; Shaywitz, BA; Spiers, PA; Stargel, WW; Tephly, TR; Thomas, JA; Trefz, FK | 1 |
| Mamori, S; Mori, Y; Tajima, N | 1 |
| Mori, Y | 1 |
| Buist, R; Owens, T; Peeling, J; Schellenberg, A; Sun, XJ; Toft-Hansen, H | 1 |
| Ryan, A; Yannicelli, S | 1 |
| Blommaert, AG; Ducos, B; Fournie-Zaluski, MC; Maldonado, R; Roques, BP; Valverde, O | 1 |
| Barber, MD; Fearon, KC; McMillan, DC; Preston, T; Ross, JA; Slater, C | 1 |
| Afzal, A; Aljada, A; Browne, R; Dandona, P; Garg, R; Ghanim, H; Hamouda, W; Mohanty, P; Prabhala, A | 1 |
| Boucher, M; Coudoré-Civiale, MA; Eschalier, A; Fournié-Zaluski, MC; Méen, M; Roques, BP | 1 |
| Feger, J; Maldonado, R; Roques, BP; Waksman, G | 1 |
2 review(s) available for phenylalanine and Weight Loss
| Article | Year |
|---|---|
Aspartame: review of safety.
Topics: Affect; Animals; Aspartame; Behavior; Brain Neoplasms; Cognition; Drug Evaluation, Preclinical; Drug Hypersensitivity; Electroencephalography; Endocrine System; Headache; Humans; Methanol; Phenylalanine; Product Surveillance, Postmarketing; Seizures; Sweetening Agents; Weight Loss | 2002 |
[Postprandial hypoglycemia].
Topics: Acarbose; Cyclohexanes; Diet, Carbohydrate-Restricted; Dietary Fiber; Dumping Syndrome; Enzyme Inhibitors; Gastrectomy; Glucose Intolerance; Glucose Tolerance Test; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Weight Loss | 2006 |
4 trial(s) available for phenylalanine and Weight Loss
| Article | Year |
|---|---|
Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECAST.
Topics: Body Weight Maintenance; Humans; Malignant Carcinoid Syndrome; Phenylalanine; Pyrimidines; Quality of Life; Treatment Outcome; Weight Loss | 2021 |
Effects of a caloric restriction weight loss diet on tryptophan metabolism and inflammatory biomarkers in overweight adults.
Topics: Austria; Biomarkers; Body Mass Index; Caloric Restriction; Diet, Reducing; Female; Humans; Inflammation Mediators; Kynurenine; Leptin; Male; Middle Aged; Mood Disorders; Neopterin; Overweight; Phenylalanine; Risk; Tryptophan; Tyrosine; Weight Loss | 2015 |
Whey protein supplementation preserves postprandial myofibrillar protein synthesis during short-term energy restriction in overweight and obese adults.
Topics: Adult; Aged; Body Mass Index; Caloric Restriction; Dietary Supplements; Double-Blind Method; Energy Intake; Female; Humans; Male; Middle Aged; Milk Proteins; Muscle, Skeletal; Myofibrils; Obesity; Overweight; Phenylalanine; Postprandial Period; Protein Biosynthesis; Soybean Proteins; Weight Loss; Whey Proteins | 2015 |
Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients.
Topics: Adult; Albumins; Eating; Female; Fibrinogen; Hormones; Humans; Kinetics; Liver; Male; Middle Aged; Pancreatic Neoplasms; Phenylalanine; Protein Biosynthesis; Ultrafiltration; Weight Loss | 2000 |
7 other study(ies) available for phenylalanine and Weight Loss
| Article | Year |
|---|---|
Weight loss-associated changes in acute effects of nateglinide on insulin secretion after glucose loading: results of glucose loading on 2 consecutive days.
Topics: Adipose Tissue; Administration, Oral; Blood Glucose; C-Peptide; Cyclohexanes; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Liver; Male; Middle Aged; Muscle, Skeletal; Nateglinide; Obesity; Phenylalanine; Weight Loss | 2005 |
Metalloproteinases control brain inflammation induced by pertussis toxin in mice overexpressing the chemokine CCL2 in the central nervous system.
Topics: Animals; Brain; Brain Diseases; Cell Movement; Central Nervous System; Chemokine CCL2; Cytokines; Female; Gene Expression Regulation; Inflammation Mediators; Injections, Intraperitoneal; Male; Metalloproteases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pertussis Toxin; Phenylalanine; Thiophenes; Weight Loss | 2006 |
Improvements in behaviour and physical manifestations in previously untreated adults with phenylketonuria using a phenylalanine-restricted diet: a national survey.
Topics: Adult; Alopecia; Appetite Regulation; Behavior; Brain Diseases, Metabolic; Diet, Protein-Restricted; Humans; Odorants; Phenylalanine; Phenylketonurias; Treatment Outcome; Weight Gain; Weight Loss | 1995 |
Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308.
Topics: Analgesics; Animals; Behavior, Animal; Binding, Competitive; Body Temperature; Diprenorphine; Disulfides; Drug Combinations; Drug Synergism; Enkephalins; Indoles; Male; Meglumine; Mice; Morphine; Motor Activity; Naloxone; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Substance Withdrawal Syndrome; Weight Loss | 1995 |
The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation.
Topics: Adult; Aged; Diet, Reducing; Female; Glucose Tolerance Test; Humans; Leukocytes; Linoleic Acid; Linoleic Acids; Linoleic Acids, Conjugated; Lipid Peroxides; Male; Middle Aged; Obesity; Phenylalanine; Proteins; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Tyrosine; Weight Loss | 2001 |
Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
Topics: Aminopeptidases; Animals; Diabetes Mellitus, Experimental; Disulfides; Drug Synergism; Indoles; Male; Meglumine; Naloxone; Naltrexone; Neprilysin; Pain; Pain Measurement; Phenylalanine; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Time Factors; Vocalization, Animal; Weight Loss | 2001 |
Naloxone-induced withdrawal syndrome after administration of selective opioid agonists or after activation of the endogenous enkephalinergic system.
Topics: Animals; Behavior, Animal; Body Temperature; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hydroxamic Acids; Naloxone; Narcotics; Oligopeptides; Phenylalanine; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Weight Loss | 1990 |